Wound Dressing Cryogel Materials Based on Poly(vinyl alcohol), Hyaluronic Acid, and Ag2O Nanoparticles
Source abstract
Abstract
Hydrogel materials based on poly(vinyl alcohol) (PVA) and silver nanoparticles are used as wound dressings. However, chemical reducing agents, ultraviolet irradiation, and radiation irradiation are mainly used to reduce silver ions to nanoparticles in hydrogel dressings. In this study, polymeric cryogel materials based on poly(vinyl alcohol), hyaluronic acid (HA), and Ag 2 O nanoparticles were synthesized by reducing silver ions with hyaluronic acid followed by freezing and thawing of the samples. Structural features, thermophysical, mechanical, antimicrobial, cytotoxic and genotoxic properties of PVA-Ag-HA polymeric cryogel materials were studied by wide-angle X-ray scattering (WAXS), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), mechanical tests, antimicrobial, cytotoxic and genotoxic studies. Studies of cryogel materials using wide-angle X-ray scattering showed that the PVA-HA composite has a higher degree of crystallinity compared to the pure PVA. It was found that during the formation of samples, silver ions are reduced in the polymer systems PVA-HA-Ag + at T = 85 °C, within 1 h with the formation of Ag 2 O nanoparticles. The addition of hyaluronic acid to the composition of PVA cryogel increases the water absorption of the samples, and a decrease in the freezing time and concentration of nanoparticles leads to an increase in the water absorption of PVA-HA cryogel materials. The thermal stability of all the studied samples, except HA, practically does not change up to a temperature of 200 °C. For the studied cryogel materials, the tensile strength increases with increasing freezing time and concentration of Ag 2 O nanoparticles up to 0.5 wt %. PVA-HA-Ag 2 O cryogel nanocomposites exhibited antimicrobial activity against Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli at silver oxide nanoparticle concentrations of ≥0.05 wt %. The obtained nanocomposites with low concentrations of Ag 2 O nanoparticles were not toxic. They did not inhibit the viability of MDCK and L-929 cell cultures at silver oxide nanoparticle concentrations of ≥0.1 wt %. When studying the genotoxic properties of cryogel materials, no mutagenic and clastogenic activity was detected. The obtained materials have potential applications for the creation of dressings for the treatment of wounds of various infectious nature.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Polymer Nanocomposite Synthesis and Irradiation · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
E.O. Paton Electric Welding Institute
The National Academy of Sciences of Ukraine
International Polish-Ukrainian Research Laboratory ADPOLCOM
Zabolotny Institute of Microbiology and Virology
National Research Center for Radiation Medicine, Hematology and Oncology
The National Academy of Medical Sciences of Ukraine
Taras Shevchenko National University of Kyiv
Centre of Polymer and Carbon Materials
The Polish Academy of Sciences
Funding
National Research Foundation of Ukraine
References (53)
Show source-provided references
1. 10.1002/adfm.20190097110.1002/adfm.201900971 ↗
2. 10.1007/s40204-014-0026-710.1007/s40204-014-0026-7 ↗
3. 10.1021/mz300451r10.1021/mz300451r ↗
4. 10.1039/b922220k10.1039/b922220k ↗
5. 10.1021/acsami.6b0562710.1021/acsami.6b05627 ↗
6. 10.1021/acs.macromol.6b0153910.1021/acs.macromol.6b01539 ↗
7. 10.1016/j.ijbiomac.2021.08.00210.1016/j.ijbiomac.2021.08.002 ↗
8. 10.1155/2021/222542610.1155/2021/2225426 ↗
9. 10.1016/j.jmbbm.2015.11.02110.1016/j.jmbbm.2015.11.021 ↗
10. 10.3390/polym1413256010.3390/polym14132560 ↗
11. 10.1021/acs.molpharmaceut.9b0102010.1021/acs.molpharmaceut.9b01020 ↗
12. 10.1080/15567036.2018.149578610.1080/15567036.2018.1495786 ↗
13. 10.1016/s0169-409x(01)00239-310.1016/s0169-409x(01)00239-3 ↗
14. 10.1080/1023666X.2018.155856710.1080/1023666X.2018.1558567 ↗
15. 10.1016/j.biomaterials.2012.01.04810.1016/j.biomaterials.2012.01.048 ↗
16. 10.1080/00914037.2019.170651010.1080/00914037.2019.1706510 ↗
17. Singh G. · J. Fundam. Pharm. Res. · 2014 · 2 · 35
18. 10.30476/tips.2019.81604.100210.30476/tips.2019.81604.1002 ↗
19. 10.1007/s10853-015-9382-510.1007/s10853-015-9382-5 ↗
20. 10.1021/acsabm.2c0003410.1021/acsabm.2c00034 ↗
21. 10.1007/s13204-020-01368-010.1007/s13204-020-01368-0 ↗
22. 10.1016/j.carbpol.2020.11643110.1016/j.carbpol.2020.116431 ↗
23. 10.1016/j.arabjc.2014.07.00510.1016/j.arabjc.2014.07.005 ↗
24. 10.1016/j.carbpol.2018.12.02110.1016/j.carbpol.2018.12.021 ↗
25. 10.1016/j.ijbiomac.2018.11.25210.1016/j.ijbiomac.2018.11.252 ↗
26. 10.1080/00222348.2019.170971410.1080/00222348.2019.1709714 ↗
27. Bahram M. · 2016
28. 10.1080/00222348.2019.161568810.1080/00222348.2019.1615688 ↗
29. 10.1016/j.ijbiomac.2018.04.01010.1016/j.ijbiomac.2018.04.010 ↗
30. 10.1016/S1369-7021(10)70202-910.1016/S1369-7021(10)70202-9 ↗
31. 10.1021/ma990758710.1021/ma9907587 ↗
32. 10.1016/j.radphyschem.2019.10836910.1016/j.radphyschem.2019.108369 ↗
33. 10.3390/pharmaceutics1309146110.3390/pharmaceutics13091461 ↗
34. 10.1016/j.ijbiomac.2020.02.04810.1016/j.ijbiomac.2020.02.048 ↗
35. 10.1007/s12668-016-0220-210.1007/s12668-016-0220-2 ↗
36. 10.3390/polym1205116710.3390/polym12051167 ↗
37. Case C. L. · 1984
38. 10.15407/microbiolj86.06.03010.15407/microbiolj86.06.030 ↗
39. 10.1101/pdb.prot08737910.1101/pdb.prot087379 ↗
40. 10.1016/S1383-5718(01)00255-810.1016/S1383-5718(01)00255-8 ↗
41. 10.1134/S156009041406004910.1134/S1560090414060049 ↗
42. 10.1038/s41598-019-46061-710.1038/s41598-019-46061-7 ↗
43. 10.1134/S0965545X1505006510.1134/S0965545X15050065 ↗
44. 10.3390/pharmaceutics1402044110.3390/pharmaceutics14020441 ↗
45. 10.1016/j.polymer.2019.03.04010.1016/j.polymer.2019.03.040 ↗
46. 10.1016/j.jddst.2020.10211110.1016/j.jddst.2020.102111 ↗
47. 10.3103/S036152190701010710.3103/S0361521907010107 ↗
48. 10.33380/2305-2066-2020-9-4-136-14010.33380/2305-2066-2020-9-4-136-140 ↗
49. 10.17221/1930-VETMED10.17221/1930-VETMED ↗
50. Agayants I. M. · Vestnik MITCHT · 2014 · 9 · 42
51. 10.1038/s41598-024-53782-x10.1038/s41598-024-53782-x ↗
52. 10.47723/kcmj.v14i1.2310.47723/kcmj.v14i1.23 ↗
53. DINENISO 10993-5:2009 · 2022